A novel mutation (insTCCG) in the TSC2 gene in a Chinese patient with Tuberous sclerosis complex

2008 ◽  
Vol 49 (1) ◽  
pp. 92-94 ◽  
Author(s):  
Cheng-Da Yuan ◽  
Xiao-Li Chang ◽  
Min Gao ◽  
Feng-Li Xiao ◽  
Yao-Qun Wu ◽  
...  
2020 ◽  
Vol 7 (3) ◽  
pp. 5-19
Author(s):  
Nikhil Nair ◽  
Ronith Chakraborty ◽  
Zubin Mahajan ◽  
Aditya Sharma ◽  
Sidarth Sethi ◽  
...  

Tuberous sclerosis complex (TSC) is a genetic condition caused by a mutation in either the TSC1 or TSC2 gene. Disruption of either of these genes leads to impaired production of hamartin or tuberin proteins, leading to the manifestation of skin lesions, tumors and seizures. TSC can manifests in multiple organ systems with the cutaneous and renal systems being the most commonly affected. These manifestations can secondarily lead to the development of hypertension, chronic kidney disease, and neurocognitive declines. The renal pathologies most commonly seen in TSC are angiomyolipoma, renal cysts and less commonly, oncocytomas. In this review, we highlight the current understanding on the renal manifestations of TSC along with current diagnosis and treatment guidelines.


2006 ◽  
Vol 105 (7) ◽  
pp. 599-603 ◽  
Author(s):  
Chih-Ping Chen ◽  
Yi-Ning Su ◽  
Chia-Cheng Hung ◽  
Jin-Chung Shih ◽  
Wayseen Wang

2017 ◽  
Vol 19 (2) ◽  
pp. 265-276 ◽  
Author(s):  
Nur Farrah Dila Ismail ◽  
Abdul Qawee Rani ◽  
Nik Mohd Ariff Nik Abdul Malik ◽  
Chia Boon Hock ◽  
Siti Nabilahuda Mohd Azlan ◽  
...  

BMC Neurology ◽  
2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Valérie Mongrain ◽  
Nicolaas H. van Doesburg ◽  
Françoise Rypens ◽  
Catherine Fallet-Bianco ◽  
Justine Maassen ◽  
...  

2009 ◽  
Vol 24 (3) ◽  
pp. 333-337 ◽  
Author(s):  
Georgia Ramantani ◽  
Pascal Niggemann ◽  
Gabriele Hahn ◽  
Andrea Näke ◽  
Raimund Fahsold ◽  
...  

2014 ◽  
Vol 97 (3) ◽  
pp. 440-444 ◽  
Author(s):  
Heung-Mo Yang ◽  
Hye-Jung Choi ◽  
Doo-Pyo Hong ◽  
Sung-Yeon Joo ◽  
Na-Eun Lee ◽  
...  

2020 ◽  
Vol 7 (3) ◽  
pp. 5-19
Author(s):  
Nikhil Nair ◽  
Ronith Chakraborty ◽  
Zubin Mahajan ◽  
Aditya Sharma ◽  
Sidharth K. Sethi ◽  
...  

Tuberous sclerosis complex (TSC) is a genetic condition caused by a mutation in either the TSC1 or TSC2 gene. Disruption of either of these genes leads to impaired production of hamartin or tuberin proteins, leading to the manifestation of skin lesions, tumors, and seizures. TSC can manifest in multiple organ systems with the cutaneous and renal systems being the most commonly affected. These manifestations can secondarily lead to the development of hypertension, chronic kidney disease, and neurocognitive declines. The renal pathologies most commonly seen in TSC are angiomyolipoma, renal cysts, and less commonly, oncocytomas. In this review, we highlight the current understanding on the renal manifestations of TSC along with current diagnosis and treatment guidelines.


2021 ◽  
Author(s):  
Jessica Dare-Shih ◽  
Adam Pillon ◽  
Jackie Fong ◽  
Elizabeth Fidalgo da Silva ◽  
Lisa Porter

Tuberin is a major component of the protein regulatory complex known as the Tuberous Sclerosis Complex and plays a crucial role in cell cycle progression and protein synthesis. Mutations in the Tuberin gene, TSC2, lead to the formation of benign tumors in many organ systems and causes the Tuberous Sclerosis Complex disorder. Genotypes ranging from point mutations to large deletions in the TSC2 gene have been clinically characterized with a wide range of phenotypes from skin tumors to large brain tumors. Our current work investigates the molecular mechanisms behind Tuberin and its ability to regulate the cell cycle through its binding to the G2/M cyclin, Cyclin B1. After creating an early stop codon in a critical region of the Tuberin, our results show the in vitro phenotype that occurs from a truncated Tuberin protein. Herein we demonstrate that this clinically relevant truncated form of Tuberin promotes an increased nuclear accumulation of Cyclin B1 and a subsequent increase in cell proliferation supporting the phenotypic data seen in the clinic with Tuberous Sclerosis Complex patients showing deletions within the TSC2 gene. This data provides an insight into some of the functional and molecular consequences of truncated proteins that are seen in clinical patients.


2010 ◽  
Vol 10 (1) ◽  
pp. 107-113 ◽  
Author(s):  
G.-X. Wang ◽  
D.-W. Wang ◽  
J.-S. Zhao ◽  
S.-F. Wang ◽  
R.-P. Sun

Sign in / Sign up

Export Citation Format

Share Document